Chemical Formula: C11H17NO3

Chemical Formula C11H17NO3

Found 57 metabolite its formula value is C11H17NO3

mescaline

1-Amino-2-(3,4,5-trimethoxyphenyl)ethane

C11H17NO3 (211.1208372)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

   

Isoproterenol

4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol

C11H17NO3 (211.1208372)


Isoproterenol is only found in individuals that have used or taken this drug. It is an isopropyl analog of epinephrine; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. [PubChem]The pharmacologic effects of isoproterenol are at least in part attributable to stimulation through beta-adrenergic receptors of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic AMP. Increased cyclic AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Orciprenaline

5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol

C11H17NO3 (211.1208372)


Orciprenaline is only found in individuals that have used or taken this drug. It is a beta-adrenergic agonist used in the treatment of asthma and bronchospasms. [PubChem]Orciprenaline is a moderately selective beta(2)-adrenergic agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle, with minimal or no effect on alpha-adrenergic receptors. Intracellularly, the actions of orciprenaline are mediated by cAMP, the production of which is augmented by beta stimulation. The drug is believed to work by activating adenylate cyclase, the enzyme responsible for producing the cellular mediator cAMP. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

Methoxamine

Glaxo wellcome brand 1 OF methoxamine hydrochloride

C11H17NO3 (211.1208372)


Methoxamine is only found in individuals that have used or taken this drug. It is an alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system. [PubChem]Methoxamine acts through peripheral vasoconstriction by acting as a pure alpha-1 adrenergic receptor agonist, consequently increasing systemic blood pressure (both systolic and diastolic). C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents KEIO_ID M169; [MS2] KO009056 KEIO_ID M169

   

methyl 2,2-dimethyl-3-[3-(hydroxyimino)-2-methyl-1-propenyl)-cyclopropanecarboxylate

methyl 2,2-dimethyl-3-[3-(hydroxyimino)-2-methyl-1-propenyl)-cyclopropanecarboxylate

C11H17NO3 (211.1208372)


   

7beta-Acetoxy-1-methoxymethyl-1,2-dehydro-8alpha-pyrrolizidin

7beta-Acetoxy-1-methoxymethyl-1,2-dehydro-8alpha-pyrrolizidin

C11H17NO3 (211.1208372)


   
   

N-Methyl-3-hydroxy-4,5-dimethoxyphenethylamine

N-Methyl-3-hydroxy-4,5-dimethoxyphenethylamine

C11H17NO3 (211.1208372)


   

Tetrahydrocantleyine

Tetrahydrocantleyine

C11H17NO3 (211.1208372)


   

methoxamine

methoxamine

C11H17NO3 (211.1208372)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

mescaline

mescaline

C11H17NO3 (211.1208372)


A phenethylamine alkaloid that is phenethylamine substituted at positions 3, 4 and 5 by methoxy groups. D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

   
   

dioxethedrin

dioxethedrin

C11H17NO3 (211.1208372)


C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   

1-(4-Aminophenoxy)-3-ethoxy-2-propanol

1-(4-Aminophenoxy)-3-ethoxy-2-propanol

C11H17NO3 (211.1208372)


   

5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate

5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate

C11H17NO3 (211.1208372)


   

tert-butyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

tert-butyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

C11H17NO3 (211.1208372)


   

tert-butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

tert-butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

C11H17NO3 (211.1208372)


   

1-(cyclobutanecarbonyl)piperidine-3-carboxylic acid

1-(cyclobutanecarbonyl)piperidine-3-carboxylic acid

C11H17NO3 (211.1208372)


   

Levisoprenaline

Levisoprenaline

C11H17NO3 (211.1208372)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

2,2-[(3-Methoxyphenyl)imino]diethanol

2,2-[(3-Methoxyphenyl)imino]diethanol

C11H17NO3 (211.1208372)


   

1-Cyclohexyl-5-Oxo-Pyrrolidine-3-Carboxylic Acid

1-Cyclohexyl-5-Oxo-Pyrrolidine-3-Carboxylic Acid

C11H17NO3 (211.1208372)


   

tert-butyl 3-ethynylmorpholine-4-carboxylate

tert-butyl 3-ethynylmorpholine-4-carboxylate

C11H17NO3 (211.1208372)


   

5-(diethylaminomethyl)-2-methylfuran-3-carboxylic acid

5-(diethylaminomethyl)-2-methylfuran-3-carboxylic acid

C11H17NO3 (211.1208372)


   

1-cyclopentyl-6-oxopiperidine-3-carboxylic acid

1-cyclopentyl-6-oxopiperidine-3-carboxylic acid

C11H17NO3 (211.1208372)


   

1-(2-HYDROXYETHYL)-4-METHANESULFONYLPIPERAZINE

1-(2-HYDROXYETHYL)-4-METHANESULFONYLPIPERAZINE

C11H17NO3 (211.1208372)


   

TERT-BUTYL 2-OXA-3-AZABICYCLO[2.2.2]OCT-5-ENE-3-CARBOXYLATE

TERT-BUTYL 2-OXA-3-AZABICYCLO[2.2.2]OCT-5-ENE-3-CARBOXYLATE

C11H17NO3 (211.1208372)


   

tert-Butyl(1R,4S)-2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

tert-Butyl(1R,4S)-2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

C11H17NO3 (211.1208372)


   

Benzenemethanamine, 3,4,5-trimethoxy-a-methyl-,(S)-

Benzenemethanamine, 3,4,5-trimethoxy-a-methyl-,(S)-

C11H17NO3 (211.1208372)


   

4-(3-Methoxypropoxy)-2,3-dimethylpyridine-N-oxide

4-(3-Methoxypropoxy)-2,3-dimethylpyridine-N-oxide

C11H17NO3 (211.1208372)


   

4-[[bis-(2-Hydroxyethyl)amino]methyl]phenol

4-[[bis-(2-Hydroxyethyl)amino]methyl]phenol

C11H17NO3 (211.1208372)


   

Benzenemethanamine, 2,3,4-trimethoxy-a-methyl-,(S)-

Benzenemethanamine, 2,3,4-trimethoxy-a-methyl-,(S)-

C11H17NO3 (211.1208372)


   

1-Propanol,2-amino-2-methyl-,benzoate

1-Propanol,2-amino-2-methyl-,benzoate

C11H17NO3 (211.1208372)


   

Ethyl 3-oxooctahydro-1H-cyclopenta[c]pyridine-4-carboxylate

Ethyl 3-oxooctahydro-1H-cyclopenta[c]pyridine-4-carboxylate

C11H17NO3 (211.1208372)


   

tert-butyl 6-oxo-3-aza-bicyclo[3.2.0]heptane-3-carboxylate

tert-butyl 6-oxo-3-aza-bicyclo[3.2.0]heptane-3-carboxylate

C11H17NO3 (211.1208372)


   

N-METHYL-3,4,5-TRIMETHOXYBENZYLAMINE

N-METHYL-3,4,5-TRIMETHOXYBENZYLAMINE

C11H17NO3 (211.1208372)


   

METHYL 4-CARBAMOYLBICYCLO[2.2.2]OCTANE-1-CARBOXYLATE

METHYL 4-CARBAMOYLBICYCLO[2.2.2]OCTANE-1-CARBOXYLATE

C11H17NO3 (211.1208372)


   

Methyl 5-[(diethylamino)methyl]-2-furoate

Methyl 5-[(diethylamino)methyl]-2-furoate

C11H17NO3 (211.1208372)


   

2-(Cyclopropylcarbamoyl)cyclohexanecarboxylic acid

2-(Cyclopropylcarbamoyl)cyclohexanecarboxylic acid

C11H17NO3 (211.1208372)


   

4-(2-oxopyrrolidin-1-yl)cyclohexane-1-carboxylic acid

4-(2-oxopyrrolidin-1-yl)cyclohexane-1-carboxylic acid

C11H17NO3 (211.1208372)


   

cis-7-Oxo-2-aza-bicyclo[3.2.0]heptane-2-carboxylic acid tert-butyl ester

cis-7-Oxo-2-aza-bicyclo[3.2.0]heptane-2-carboxylic acid tert-butyl ester

C11H17NO3 (211.1208372)


   

tert-Butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate

tert-Butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate

C11H17NO3 (211.1208372)


   

TERT-BUTYL 5-OXO-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE

TERT-BUTYL 5-OXO-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE

C11H17NO3 (211.1208372)


   

[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methanol

[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methanol

C11H17NO3 (211.1208372)


   

DIETHYLAMINE SALICYLATE

DIETHYLAMINE SALICYLATE

C11H17NO3 (211.1208372)


   

DL-BETA-(3,4-DIMETHOXYPHENYL)ALANINOL

DL-BETA-(3,4-DIMETHOXYPHENYL)ALANINOL

C11H17NO3 (211.1208372)


   

1-(3-(TRIFLUOROMETHYL)PHENETHYL)HYDRAZINE

1-(3-(TRIFLUOROMETHYL)PHENETHYL)HYDRAZINE

C11H17NO3 (211.1208372)


   
   
   
   

TMPEA

4-13-00-02919 (Beilstein Handbook Reference)

C11H17NO3 (211.1208372)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

   

(2S,3R,4R)-1-(4-aminophenyl)pentane-2,3,4-triol

(2S,3R,4R)-1-(4-aminophenyl)pentane-2,3,4-triol

C11H17NO3 (211.1208372)


   
   

isoproterenol

DL-Isoproterenol

C11H17NO3 (211.1208372)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

orciprenaline

metaproterenol

C11H17NO3 (211.1208372)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   
   

methyl (4as,6s,7r,7as)-6-hydroxy-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridine-4-carboxylate

methyl (4as,6s,7r,7as)-6-hydroxy-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridine-4-carboxylate

C11H17NO3 (211.1208372)


   

methyl 6-hydroxy-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridine-4-carboxylate

methyl 6-hydroxy-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridine-4-carboxylate

C11H17NO3 (211.1208372)